Cadherin 23 as a Marker for Pancreatic Cancer Prognosis
Author Information
Author(s): Zhen Chaohui, Sun Peiwei, Liang Rui, Fei Shuang, Chen Xu, Qian Junlin, Xu Baoshi, Lin QiRui, Yao Guojun, Zheng Biao
Primary Institution: The First Dongguan Affiliated Hospital, Guangdong Medical University
Hypothesis
This study investigates the role and mechanism of Cadherin 23 (CDH23) in the viability of pancreatic cancer cells.
Conclusion
High levels of CDH23 expression are correlated with a poor prognosis in pancreatic cancer and may serve as a novel prognostic marker.
Supporting Evidence
- High CDH23 expression was associated with shorter overall survival.
- CDH23 expression correlated with local recurrence and distant metastasis.
- Silencing CDH23 decreased cell viability in floating culture conditions.
Takeaway
This study found that a protein called Cadherin 23 can help predict how well someone with pancreatic cancer might do, with higher levels meaning a worse outcome.
Methodology
The study examined CDH23 expression in 70 surgical pancreatic cancer samples and assessed cell viability in various culture conditions after silencing CDH23 expression.
Participant Demographics
{"median_age":"67 years","sex_distribution":{"male":46,"female":24}}
Statistical Information
P-Value
0.0021
Confidence Interval
1.307-4.228
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website